首页 正文

An evaluation of datopotamab deruxtecan for the treatment of non-small cell lung cancer

{{output}}
Introduction: Despite recent treatment breakthroughs, non-small cell lung cancer (NSCLC) remains the highest cause of cancer-related mortality. New therapies are urgently needed, particularly in patients without actionable genomi... ...